These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 3682957)

  • 41. Antituberculous drugs.
    Yoshikawa TT; Fujita NK
    Med Clin North Am; 1982 Jan; 66(1):209-19. PubMed ID: 6801402
    [No Abstract]   [Full Text] [Related]  

  • 42. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service/British Medical Research Council.
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):700-6. PubMed ID: 1901199
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Proceedings: Ambulatory chemotherapy of tuberculosis in Finland (organization)].
    Pätiälä J; Tani P
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):123-8. PubMed ID: 4128939
    [No Abstract]   [Full Text] [Related]  

  • 44. Effects on the QT Interval of a Gatifloxacin-Containing Regimen versus Standard Treatment of Pulmonary Tuberculosis.
    Olliaro PL; Merle C; Mthiyane T; Bah B; Kassa F; Amukoye E; N Diaye A; Perronne C; Lienhardt C; McIlleron H; Fielding K
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28438924
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
    Ahn HC; Lee YC
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of tuberculosis today in Nebraska.
    Burgher LW; Kass I
    Nebr Med J; 1973 May; 58(5):156-62. PubMed ID: 4348990
    [No Abstract]   [Full Text] [Related]  

  • 49. Side-effects of drug regimens used in short-course chemotherapy for pulmonary tuberculosis. A controlled clinical study.
    Zierski M; Bek E
    Tubercle; 1980 Mar; 61(1):41-9. PubMed ID: 6989067
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
    Negi SS; Gupta S; Lal S
    J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antituberculous drug resistance in central Haiti.
    Scalcini M; Carré G; Jean-Baptiste M; Hershfield E; Parker S; Wolfe J; Nelz K; Long R
    Am Rev Respir Dis; 1990 Sep; 142(3):508-11. PubMed ID: 2117870
    [TBL] [Abstract][Full Text] [Related]  

  • 52. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Treatment of pleuropulmonary tuberculosis in 1985].
    Sandron D; Marin I; Huchon G
    Ann Med Interne (Paris); 1985; 136(1):59-68. PubMed ID: 3890662
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. VII. September 1965 to September 1969.
    Hobby GL; Johnson PM; Boytar-Papirnyik V
    Am Rev Respir Dis; 1970 Sep; 102(3):347-55. PubMed ID: 4989604
    [No Abstract]   [Full Text] [Related]  

  • 55. Basic mechanisms of chemotherapy.
    Mitchison DA
    Chest; 1979 Dec; 76(6 Suppl):771-81. PubMed ID: 92392
    [No Abstract]   [Full Text] [Related]  

  • 56. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 57. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.
    Ige OM; Bakare NA; Onadeko BO
    Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Fixed drug eruption after taking ethambutol].
    Bakayoko AS; Kaloga M; Kamagate M; Kone Z; Daix AT; Ohui E; Gbery I; Domoua K
    Rev Mal Respir; 2015 Jan; 32(1):48-51. PubMed ID: 25618204
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Consequences of the development of new antituberculous drugs for the treatment of tuberculosis.
    Freerksen E
    Antibiot Chemother; 1970; 16():524-9. PubMed ID: 5523735
    [No Abstract]   [Full Text] [Related]  

  • 60. [Tuberculosis treatment today].
    Sjögren I; Boman G; Löfdahl CG; Skoogh BE
    Lakartidningen; 1984 Dec; 81(49):4655-9. PubMed ID: 6521569
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.